Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Nat Rev Drug Discov. 2022 Nov;21(11):793–794. doi: 10.1038/d41573-021-00190-9

Figure 2. Clinical development times for innovative drugs as a function of therapeutic class and molecule type.

Figure 2.

a. Therapeutic class; one-way ANOVA P = 0.04. b. Molecule type; one-way ANOVA P < 0.01. See Supplementary Box 1 for details of the analysis.